Covaxin of Bharat Biotech

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals

Dhanraj SharmaJuly 3, 2021

In what Hyderabad-based Bharat Biotech claims is the largest efficacy trial in India across 25 trial sites, the company claims its Covid-19 vaccine Covaxin is 65 per cent effective against...

COVID-19

Bharat Biotech to sell Covaxin at Rs 600 to States, Rs 1200 to private hospitals

CS SURBHI SAXENAApril 25, 2021

Bharat Biotech has announced the cost of COVAXIN for State governments and Private Hospitals. It will cost 600 rupees per dose for State Governments and 1200 rupees per dose for...

COVID-19

Covid vaccine manufacturers SII and Bharat Biotech get financial assistance from government to ramp up vaccine production

CS SURBHI SAXENAApril 20, 2021April 20, 2021

Union Finance Minister has approved a total of Rupees 4,567.50 crore as advance payment to Covishield and Covaxin manufacturers Serum Institute of India (SII) and Bharat Biotech to ramp up...

NATIONAL NEWS

5,63,500 doses of COVID vaccine delivered to different States

CS SURBHI SAXENAJanuary 14, 2021January 14, 2021

AIR
All preparations for the first phase of COVID vaccination have been completed. Today, 5,63,500 doses of vaccine were received by the State. Of these, 4,43,500 doses are Covishield vaccine of Serum Institute of India, while 20,000 vaccine doses are Covaxin of Bharat Biotech.

Tag: Covaxin of Bharat Biotech

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals

Bharat Biotech to sell Covaxin at Rs 600 to States, Rs 1200 to private hospitals

Covid vaccine manufacturers SII and Bharat Biotech get financial assistance from government to ramp up vaccine production

5,63,500 doses of COVID vaccine delivered to different States

Read on App

Cabinet approves India UAE MoU for scientific and technical cooperation

WMTPA Calls for Nationwide Protest against GST and Income Tax Issues